REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/01/2025
Back to search
Official data from USPTO
NUCLEIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NUCLEIX
ST13
US500000088549443Class
1, 5, 10, 42, 44
Filing
88549443
Registration
6208606
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
12/02/2025
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
07/30/2019
Registration date
12/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2020
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Tel-Aviv, IL
Examiner
SABAGH,LAILA TAREK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nucleix, Ltd.
Nucleix, Ltd.
Representatives
Jennifer Sheehan Anderson BRIDGE INTELLECTUAL PROPERTY SERVICES
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory use
Class 5
Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection; diagnostic reagents for medical purposes
Class 10
Apparatus for medical diagnostic testing in the field of cancer
Class 42
Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays
Class 44
Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and prognosis of expected progression of the disease; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer; providing cancer screening services; providing a website featuring information in the fields of the diagnosis and treatment of cancer
Publications
History of USPTO decisions and trademark events.
28 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/16/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/16/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/16/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/16/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/16/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/15/2020
PUBO
PUBLISHED FOR OPPOSITION
09/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2020
OTHE
CASE RETURNED TO EXAMINATION
08/13/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/11/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
08/03/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
08/03/2020
APET
ASSIGNED TO PETITION STAFF
08/03/2020
44EP
44(e) PETITION - RECEIVED
08/03/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE
04/16/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/16/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/18/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/17/2019
PUBO
PUBLISHED FOR OPPOSITION
12/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/27/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2019
DOCK
ASSIGNED TO EXAMINER
10/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2019
NWAP
NEW APPLICATION ENTERED
08/02/2019
Continuous trademark protection
Get notified about every new filing that threatens NUCLEIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.